Daily non-political popular news in brief.

Once-a-year drug reduces fractures from osteoporosis

05-02-2007 · EurekAlert!

A treatment for osteoporosis delivered once a year is as effective as current monthly or weekly osteoporosis regimens at reducing the incidence of bone fractures, according to a new study led by a UCSF research team.

Keywords: once-a-year, drug, fractures, osteoporosis, once, year, fracture, osteoporosi

« Previous | Next »

Similar news on "Once-a-year drug reduces fractures from osteoporosis":

Women may be able to 'take break' from osteoporosis drug without losing benefit
12-26-2006 · EurekAlert!
Most postmenopausal women who took the osteoporosis drug alendronate for 5 years and then stopped did not have an increased risk for nonvertebral fractures in the next 5 years, suggesting the medication has a lasting effect, according to a study in the December 27 issue of JAMA.
Similar news · Read more »
Less Is More (Bone): Yearly osteoporosis drug reduces fractures
05-05-2007 · Science News Online
Older women with osteoporosis who received yearly infusions of a drug that prevents bone loss had far fewer fractures than did peers who didn't get the drug.
Similar news · Read more »
High-trauma fractures in older adults linked to osteoporosis, increased risk of another fracture
11-27-2007 · EurekAlert!
Contrary to a widely held assumption, high-trauma nonspine fractures in older women and men, such as from a car crash, are associated with low bone mineral density and an increased risk of a subsequent fracture, according to a study in the Nov. 28 issue of JAMA. These findings suggest that older adults who experience these fractures should be evaluated for osteoporosis.
Similar news · Read more »
New study shows Actonel almost halves the risk of hip fractures compared to alendronate
11-17-2006 · EurekAlert!
Data published today from a retrospective study of over 33,000 postmenopausal women showed that among patients newly prescribed one of the two most popular osteoporosis treatments, patients taking Actonel® (risedronate sodium) were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. These results were published today in the peer-reviewed journal Osteoporosis International.1
Similar news · Read more »
High-trauma fractures in older men and women linked to osteoporosis
11-28-2007 · EurekAlert!
Researchers at the California Pacific Medical Center Research Institute are challenging a widely held belief that fractures resulting from major trauma, such as automobile accidents, are not related to osteoporosis, the common disease that makes bones weak and prone to fracture. Their study, funded by the National Institutes of Health, was published in the Nov. 28 issue of the Journal of the American Medical Association.
Similar news · Read more »
Men told to watch their step -- consequences of the failure to treat osteoporosis
01-23-2007 · EurekAlert!
Garvan scientists say that men need to realize osteoporosis is not just a disease of elderly women and that once men over the age of 60 have had a fracture, around one in three will have broken another bone within just a few years.
Similar news · Read more »
Once-yearly treatment significantly reduces bone fractures in women with postmenopausal osteoporosis
05-02-2007 · EurekAlert!
Phase III clinical trial shows effectiveness of once-yearly treatment for postmenopausal osteoporosis.
Similar news · Read more »
Bone Builder: Drug may offer steroid users new protection against fractures
11-17-2007 · Science News Online
A bone-growth medication called teriparatide outperforms the standard bone-preserving drug alendronate in people with steroid-induced osteoporosis.
Similar news · Read more »
Women on osteoporosis drug can discontinue use with no risk
12-26-2006 · EurekAlert!
A long-term study of the most widely used osteoporosis drug has found that many women can discontinue the drug after five years without increasing their fracture risk for as long as five more years.
Similar news · Read more »
New drug targets may fight tuberculosis and other bacterial infections in novel way
12-27-2007 · EurekAlert!
Researchers from Weill Cornell Medical College in New York City say exciting new molecular targets -- so-called "virulence factors" that bacteria use to thrive once they are in the host -- present an alternative, potent means of stopping TB, leprosy and other bacterial illness.
Similar news · Read more »